KPIs & Operating Metrics(New)
Growth Metrics

Charles River Laboratories International (CRL) Shares Outstanding (Diluted Average) (2016 - 2025)

Charles River Laboratories International has reported Shares Outstanding (Diluted Average) over the past 10 years, most recently at $49.6 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Diluted Average) at $49.6 million for Q4 2025, down 4.0% from a year ago — trailing twelve months through Dec 2025 was $49.6 million (down 4.0% YoY), and the annual figure for FY2025 was $49.6 million, down 4.0%.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $49.6 million at Charles River Laboratories International, roughly flat from $49.4 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for CRL hit a ceiling of $51.8 million in Q2 2024 and a floor of $49.4 million in Q3 2025.
  • Median Shares Outstanding (Diluted Average) over the past 5 years was $51.4 million (2021), compared with a mean of $51.2 million.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): grew 2.22% in 2021 and later decreased 4.42% in 2025.
  • Charles River Laboratories International's Shares Outstanding (Diluted Average) stood at $51.4 million in 2021, then decreased by 0.24% to $51.3 million in 2022, then grew by 0.29% to $51.5 million in 2023, then increased by 0.34% to $51.6 million in 2024, then decreased by 4.0% to $49.6 million in 2025.
  • The last three reported values for Shares Outstanding (Diluted Average) were $49.6 million (Q4 2025), $49.4 million (Q3 2025), and $50.1 million (Q2 2025) per Business Quant data.